These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32025647)

  • 1. A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients.
    Pishvaian MJ; Blais EM; Bender RJ; Rao S; Boca SM; Chung V; Hendifar AE; Mikhail S; Sohal DPS; Pohlmann PR; Moore KN; He K; Monk BJ; Coleman RL; Herzog TJ; Halverson DD; DeArbeloa P; Petricoin EF; Madhavan S
    JAMIA Open; 2019 Dec; 2(4):505-515. PubMed ID: 32025647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual Clinical and Precision Medicine Tumor Boards-Cloud-Based Platform-Mediated Implementation of Multidisciplinary Reviews Among Oncology Centers in the COVID-19 Era: Protocol for an Observational Study.
    Blasi L; Bordonaro R; Serretta V; Piazza D; Firenze A; Gebbia V
    JMIR Res Protoc; 2021 Sep; 10(9):e26220. PubMed ID: 34387553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of virtual molecular tumor boards for informed clinical decision-making.
    Angel M; Demiray M; Dişel U; Passos J
    Oncologist; 2024 Jul; 29(7):554-559. PubMed ID: 38761380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
    Keller RB; Mazor T; Sholl L; Aguirre AJ; Singh H; Sethi N; Bass A; Nagaraja AK; Brais LK; Hill E; Hennessey C; Cusick M; Del Vecchio Fitz C; Zwiesler Z; Siegel E; Ovalle A; Trukhanov P; Hansel J; Shapiro GI; Abrams TA; Biller LH; Chan JA; Cleary JM; Corsello SM; Enzinger AC; Enzinger PC; Mayer RJ; McCleary NJ; Meyerhardt JA; Ng K; Patel AK; Perez KJ; Rahma OE; Rubinson DA; Wisch JS; Yurgelun MB; Hassett MJ; MacConaill L; Schrag D; Cerami E; Wolpin BM; Nowak JA; Giannakis M
    JCO Precis Oncol; 2023 Jan; 7():e2200342. PubMed ID: 36634297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer.
    Gebbia V; Guarini A; Piazza D; Bertani A; Spada M; Verderame F; Sergi C; Potenza E; Fazio I; Blasi L; La Sala A; Mortillaro G; Roz E; Marchese R; Chiarenza M; Soto-Parra H; Valerio MR; Agneta G; Amato C; Lipari H; Baldari S; Ferraù F; Di Grazia A; Mancuso G; Rizzo S; Firenze A
    Pulm Ther; 2021 Dec; 7(2):295-308. PubMed ID: 34089169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase.
    Holt ME; Mittendorf KF; LeNoue-Newton M; Jain NM; Anderson I; Lovly CM; Osterman T; Micheel C; Levy M
    JCO Clin Cancer Inform; 2021 Sep; 5():995-1004. PubMed ID: 34554823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants.
    Li X; Warner JL
    Front Cell Dev Biol; 2020; 8():48. PubMed ID: 32117976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices.
    Rao S; Pitel B; Wagner AH; Boca SM; McCoy M; King I; Gupta S; Park BH; Warner JL; Chen J; Rogan PK; Chakravarty D; Griffith M; Griffith OL; Madhavan S
    JCO Clin Cancer Inform; 2020 Jul; 4():602-613. PubMed ID: 32644817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
    Vodicska B; Déri J; Tihanyi D; Várkondi E; Kispéter E; Dóczi R; Lakatos D; Dirner A; Vidermann M; Filotás P; Szalkai-Dénes R; Szegedi I; Bartyik K; Gábor KM; Simon R; Hauser P; Péter G; Kiss C; Garami M; Peták I
    World J Pediatr; 2023 Oct; 19(10):992-1008. PubMed ID: 36914906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center.
    Jain NM; Schmalz L; Cann C; Holland A; Osterman T; Lang K; Wiesner GL; Pal T; Lovly C; Stricker T; Micheel C; Balko JM; Johnson DB; Park BH; Iams W
    Oncologist; 2021 Nov; 26(11):e1962-e1970. PubMed ID: 34390291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Software-Tool Support for Collaborative, Virtual, Multi-Site Molecular Tumor Boards.
    Schapranow MP; Borchert F; Bougatf N; Hund H; Eils R
    SN Comput Sci; 2023; 4(4):358. PubMed ID: 37131499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.
    Dalton WB; Forde PM; Kang H; Connolly RM; Stearns V; Gocke CD; Eshleman JR; Axilbund J; Petry D; Geoghegan C; Wolff AC; Loeb DM; Pratilas CA; Meyer CF; Christenson ES; Slater SA; Ensminger J; Parsons HA; Park BH; Lauring J
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 30003184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges.
    Ekhator C; Kesari S; Tadipatri R; Fonkem E; Grewal J
    Cureus; 2022 Jun; 14(6):e25682. PubMed ID: 35677741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Large Language Models for Decision Support in Personalized Oncology.
    Benary M; Wang XD; Schmidt M; Soll D; Hilfenhaus G; Nassir M; Sigler C; Knödler M; Keller U; Beule D; Keilholz U; Leser U; Rieke DT
    JAMA Netw Open; 2023 Nov; 6(11):e2343689. PubMed ID: 37976064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.
    Tamborero D; Dienstmann R; Rachid MH; Boekel J; Lopez-Fernandez A; Jonsson M; Razzak A; Braña I; De Petris L; Yachnin J; Baird RD; Loriot Y; Massard C; Martin-Romano P; Opdam F; Schlenk RF; Vernieri C; Masucci M; Villalobos X; Chavarria E; ; Balmaña J; Apolone G; Caldas C; Bergh J; Ernberg I; Fröhling S; Garralda E; Karlsson C; Tabernero J; Voest E; Rodon J; Lehtiö J
    Nat Cancer; 2022 Feb; 3(2):251-261. PubMed ID: 35221333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular tumour boards - current and future considerations for precision oncology.
    Tsimberidou AM; Kahle M; Vo HH; Baysal MA; Johnson A; Meric-Bernstam F
    Nat Rev Clin Oncol; 2023 Dec; 20(12):843-863. PubMed ID: 37845306
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.